ALOX5 and hepatocellular carcinoma: 5-LOX, a catalyzing enzyme of arachidonic acid, was overexpressed during multistage tumor progression in many neoplastic disorders including lung, breast, pancreatic cancers and HCC HBx-integrated host hepatocytes [32], [33].